Guoping Cheng
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 8
- Cancer Cells and Metastasis 3
- Lung Cancer Research Studies 3
-
- Wnt/β-catenin signaling in development and cancer 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Zhengbo Song (6 shared papers)Kaiyan Chen (6 shared papers)Fanrong Zhang (5 shared papers)Yiping Zhang (3 shared papers)Yanjun Xu (3 shared papers)Xinmin Yu (1 shared paper)Zhijian Cai (2 shared papers)Gensheng Zhang (1 shared paper)
- Journals
- OncoTargets and Therapy (4 papers)Cell Death and Disease (3 papers)Oncotarget (3 papers)Lung Cancer (2 papers)International Journal of Colorectal Disease (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Guoping Cheng
38 papers receiving 829 citations
Peers
Comparison fields: 5 of 85
- Oncology 373
- Cancer Research 148
- Pulmonary and Respiratory Medicine 251
- Immunology 118
- Health Informatics 4
Countries citing papers authored by Guoping Cheng
This map shows the geographic impact of Guoping Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoping Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoping Cheng more than expected).
Fields of papers citing papers by Guoping Cheng
This network shows the impact of papers produced by Guoping Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoping Cheng. The network helps show where Guoping Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Guoping Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 143 | |
| 2 | 2016 | 92 | |
| 3 | 2020 | 66 | |
| 4 | 2016 | 63 | |
| 5 | 2020 | 45 | |
| 6 | 2022 | 44 | |
| 7 | 2018 | 39 | |
| 8 | 2017 | 26 | |
| 9 | 2017 | 23 | |
| 10 | 2019 | 21 | |
| 11 | 2021 | 19 | |
| 12 | 2020 | 19 | |
| 13 | 2018 | 18 | |
| 14 | 2021 | 17 | |
| 15 | 2022 | 17 | |
| 16 | 2022 | 17 | |
| 17 | 2020 | 17 | |
| 18 | 2015 | 15 | |
| 19 | 2017 | 14 | |
| 20 | 2001 | 14 |
About Guoping Cheng
Guoping Cheng is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Immunology, having authored 38 papers that have together received 833 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Cells and Metastasis (3 papers), Lung Cancer Research Studies (3 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Epigenetics and DNA Methylation (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Oncology (373 citations), Cancer Research (148 citations), Pulmonary and Respiratory Medicine (251 citations), Immunology (118 citations) and Health Informatics (4 citations). Guoping Cheng has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhengbo Song, Kaiyan Chen, Fanrong Zhang, Yiping Zhang, Yanjun Xu, Xinmin Yu, Zhijian Cai, Gensheng Zhang, Huiqing Xiu and Yanmei Peng. Their work appears in journals such as OncoTargets and Therapy, Cell Death and Disease, Oncotarget, Lung Cancer and International Journal of Colorectal Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.